JACQUALINE GERVAIS: Open Payments
NPI 1336481803 · MOORHEAD, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,511 in 26 payments from 7 companies in 2025. Trend: 2023 $16,605 · 2024 $4,089 · 2025 $8,511
Speaker / faculty: $7,000Travel & lodging: $976Food & beverage: $535
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $8,065 |
| Janssen Pharmaceuticals, Inc | 2 | $199 |
| Axsome Therapeutics, Inc. | 3 | $147 |
| Neurocrine BioSciences, Inc. | 2 | $33 |
| Alkermes, Inc. | 1 | $26 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
Products named: VRAYLAR, INVEGA SUSTENNA, Auvelity, INGREZZA, ARISTADA, COBENFY, CAPLYTA.
Industry payments across MN — which companies pay providers there.
